Association between cardiac atrioventricular conduction and antibodies to Chlamydia pneumoniae in fibromyalgia patients.
Basant K PuriGeorgia TuckeyLucy CowansGary S LeeArmin SchwarzbachPublished in: Recent advances in inflammation & allergy drug discovery (2023)
This study supports the hypothesis of an association between atrioventricular conduction and antibodies to Chlamydia pneumoniae in fibromyalgia patients. It suggests that the higher the level of such antibodies, the greater the electrocardiographic PR interval, and therefore the slower the atrioventricular conduction. Potential pathophysiological mechanisms include a chronic inflammatory response to Chlamydia pneumoniae and the action of the bacterial lipopolysaccharide. The latter may involve stimulators of interferon genes, activation of the cardiac NOD-like receptor protein 3 inflammasomes, and downregulation of fibroblast growth factor 5 in the heart.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- left ventricular
- prognostic factors
- peritoneal dialysis
- cell proliferation
- inflammatory response
- patient reported outcomes
- signaling pathway
- oxidative stress
- dendritic cells
- risk assessment
- small molecule
- catheter ablation
- left atrial
- patient reported
- drug induced
- human health
- amino acid